When Expo 2020 officially confirmed its year-long delay on 4 May 2020, the Covid-19 virus held the upper hand on global economies. Healthcare services across the world were under immense pressure and there seemed to be no end in sight.
By the end of 2020, the situation was quite different. The virus is still around, and many nations are experiencing a second wave of infections. But two things have changed: The first is that governments, businesses and individuals have learned to better cope with the ‘invisible’ enemy. The second is that there is now an increasingly clear path towards the manufacture and distribution of vaccines, and several leading examples are on the cusp of being rolled out on mass.